• Acker, B., Hoppe, R.T., Colby, T.V., Cox, R.S., Kaplan, H.S. & Rosenberg, S.A. (1983) Histologic conversion in non Hodgkin’s lymphomas. Journal of Clinical Oncology, 1, 1116.
  • Camacho, F., Mollejo, M., Mateo, M., Algara, P., Navas, C., Hernandez, J., Santoja, C., Sole, F., Sanchez-Beato, M. & Piris, M.A. (2001) Progression to large B cell lymphoma in Splenic Marginal Zone Lymphoma. American Journal of Surgical Pathology, 25, 12681276.
  • Catovsky, D. & Matutes, E. (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Seminars in Hematology, 36, 148154.
  • Heintel, D., Streubel, B., Welzel, N., Le, T., Schwarzinger, I., Haas, O.A., Simonitsch, I., Lechner, K. & Jaeger, U. (2003) Burkitt lymphoma following splenic marginal zone lymphoma. Cancer Genetics and Cytogenetics, 141, 8688.
  • Horning, S.J. & Rosenberg, S.A. (1984) The natural history of initially untreated low grade non Hodgkin’s lymphomas. New England Journal of Medicine, 311, 14711475.
  • Mateo, M., Mollejo, M., Villundas, R., Algara, P., Sanchez-Beato, M., Martinez, P. & Piris, M.A. (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. American Journal of Pathology, 154, 15831589.
  • Matutes, E., Morilla, R., Owusu-Ankomah, K., Houlihan, A. & Catovsky, D. (1994) The immunophenotype of splenic lymphoma with circulating villous lymphocytes and its reference to the differential diagnosis with other B cell disorders. Blood, 83, 15581562.
  • Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z.S. & Lister, T.A. (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25, 24262433.
  • Mulligan, S.P., Matutes, E., Dearden, C.E. & Catovsky, D. (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology, 78, 206209.
  • Parry-Jones, N., Matutes, E., Gruszka-Westwood, A., Swansbury, J., Wotherspoon, A. & Catovsky, D. (2003) Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. British Journal of Haematology, 120, 759764.
  • Robertson, L.E., Pugh, W., O’Brien, S., Kantarjian, H., Hirsch-Ginsberg, C., Cork, A., McLaughlin, P., Cabanillas, F. & Keating, M.J. (1993) Richter’s syndrome: a report on 39 patients. Journal of Clinical Oncology, 11, 19851989.
  • Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S. & Raffeld, M. (1993) p53 mutation is associated with progression in follicular lymphomas. Blood, 82, 19942004.
  • Sole, F., Salido, M., Espinet, B., Garcia, J.L., Martinez Climent, J.A., Granada, I., Hernández, J.M., Benet, I., Piris, M.A., Mollejo, M., Martinez, P., Vallespí, T., Domingo, A., Serrano, S., Woessner, S. & Florensa, L. (2000) Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Hematologica, 86, 7177.
  • Thornton, P., Bellas, C., Santon, A., Shah, G., Pocock, C., Wotherspoon, A.C., Matutes, E. & Catovsky, D. (2005) Richter’s transformation of chronic lymphocytic leukaemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leukemia Research, 29, 389395.
  • Tsimberidou, A.M., O’Brien, S., Khouri, I., Giles, F.J., Kantarjian, H.M., Champlin, R., Wen, S., Do, K.A., Smith, S.C., Lerner, S., Freireich, E.J. & Keating, M.J. (2006) Clinical outcomes and prognostic factors in patients with Richter’s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. Journal of Clinical Oncology, 24, 23432351.